GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human tryptase with potent non-peptide inhibitor

Analyse Crystal structure of human tryptase with potent non-peptide inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ZA5
Type
protein
Length
968 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tryptase beta 2
EC
3.4.21.59
UniProt
Q6B052
Ligands
2FF
Pockets
13 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 11% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DTryptase beta 2 (EC 3.4.21.59)protein24211% helix, 36% strandQ6B052

Ligands and binding sites

  • 2FF · (5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone · ligand · 4 copies · chains A, C, B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12570.550.7632empty
22730.540.7634empty
31460.480.78352FF
41310.450.77202FF
51150.440.78212FF

Interfaces

4 interfaces between chains.

  • B–D · 1116 Ų buried · 20 hydrogen bonds · protein-protein
  • A–C · 1113 Ų buried · 21 hydrogen bonds · protein-protein
  • A–D · 437 Ų buried · 1 hydrogen bond · protein-protein
  • B–C · 428 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 16 disulfide (disulfide).

Compared structures

  • 2ZA5 · Crystal Structure of human tryptase with potent non-peptide inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.